“Access to medicine is an issue for everybody, a cross-border issue that goes beyond domestic interests.”

Dr. Jayasree K. Iyer

Executive Director
Access to Medicine Foundation

STAKEHOLDER INTERVIEWS

“When we all come together and look at the world in a positive way and look at what is possible, we can achieve extraordinary things. ”

Dr. Mark Dybul

Former Executive Director
The Global Fund to Fight AIDS,
Tuberculosis and Malaria

STAKEHOLDER INTERVIEWS

“My hope is that some GHIT projects will lead to products that can be provided to patients in endemic regions of infectious diseases.”

Prof. Kiyoshi Kita

Dean, Nagasaki University School of Tropical Medicine and Global Health

STAKEHOLDER
INTERVIEWS

“It is a great honor that our technology can help address social problems.”

SPONSOR INTERVIEWS

NEWSJourney with us through GHIT’s Past and Future

  • 2017.06.05 NEWS GHIT Fund 5th Anniversary Film Released
  • 2017.06.01 NEWS New content "GHIT FUTURE" has been added
  • 2017.06.01 NEWS New interview articles have been released
  • 2017.05.10 NEWS New interview articles have been released
  • 2017.04.10 NEW SITE OPEN NEW GHIT Fund 5th Anniversary Website Launched

GHIT FUND HISTORYOur first 5 years (2013-2017)

GHIT FUND FUTUREPlans for the next 5 years (2018-2022)

STAKEHOLDER INTERVIEWSPerspectives from 15 global health leaders on
GHIT's catalytic role and Japan's transformational
contributions to global health R&D

GHIT Fund 5th Anniversary Film

FUNDING

Dr. Naoko YamamotoAssistant Minister for Global Health
Minister's Secretariat
Ministry of Health, Labour and Welfare
Dr. Hannah KettlerSenior Program Officer, Life Science Partnerships
Global Health Program, Office of the President
Bill & Melinda Gates Foundation

Available in August 2017

Prof. Stephen CaddickDirector, Innovations Division,
Wellcome Trust

DISCOVERY

Dr. David ReddyCEO
Medicine for Malaria Venture (MMV)
Mr. George NakayamaRepresentative Director, Chairman and CEO
Daiichi Sankyo Company, Limited
Prof. Kiyoshi KitaProfessor Emeritus, The University of Tokyo
Professor and Dean, Nagasaki University School of Tropical Medicine and Global Health

DEVELOPMENT

Mr. Christophe WeberRepresentative Director, President and CEO
Takeda Pharmaceutical Company Limited
Mr. Yoshihiko HatanakaRepresentative Director, President and CEO
Astellas Pharma Inc.

Available in July 2017

Dr. Nathalie Strub WourgaftMedical Officer
Drugs for Neglected Diseases initiative (DNDi)

ACCESS

Dr. Jayasree K. IyerExecutive Director
Access to Medicine Foundation

Available in July 2017

Mr. Tetsuo KondoDirector
UNDP Representation Office in Tokyo

Available in August 2017

Dr. Aya YajimaTechnical Officer
Malaria, other Vectorborne and Parasitic Diseases Unit
Division of Communicable Diseases
World Health Organization Western Pacific Regional Office

POLICY

Dr. Mark DybulExecutive Director
Global Fund

Available in July 2017

Dr. Seth BerkleyCEO
Gavi

Available in August 2017

Hon. Prof. Keizo TakemiMember of the House of Councillors of Japan
Chairman, Special Committee onGlobal Health Strategy
of the Liberal Democratic Party's Policy

SPONSOR INTERVIEWSOur shared vision drives creative partnerships for global health innovation

All Nippon Airways
Yahoo! JAPAN
salesforce.com Co.,Ltd.
MORRISON FOERSTER

Available in July 2017

Mori Building Co., Ltd.

Available in August 2017

STAFF STORYDiverse paths lead to global health R&D

Coming Fall 2017